Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Pliant Therapeutics (PLRX) Receivables - Other (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Receivables - Other for 6 consecutive years, with $823000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 64.25% to $823000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $823000.0, a 64.25% decrease, with the full-year FY2025 number at $823000.0, down 64.25% from a year prior.
  • Receivables - Other was $823000.0 for Q4 2025 at Pliant Therapeutics, down from $908000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $3.0 million in Q4 2023 to a low of $320000.0 in Q2 2022.
  • A 5-year average of $1.5 million and a median of $1.5 million in 2025 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: plummeted 95.86% in 2021, then surged 639.06% in 2023.
  • Pliant Therapeutics' Receivables - Other stood at $385000.0 in 2021, then skyrocketed by 180.0% to $1.1 million in 2022, then skyrocketed by 178.01% to $3.0 million in 2023, then fell by 23.19% to $2.3 million in 2024, then tumbled by 64.25% to $823000.0 in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Receivables - Other are $823000.0 (Q4 2025), $908000.0 (Q3 2025), and $1.5 million (Q2 2025).